COVID-19 Vaccine in Pregnancy: Safety, Timing & Indian Guidance

• COVID-19 vaccination is recommended in any trimester of pregnancy by WHO, ACOG, RCOG, FOGSI and IAP — there is no "unsafe" stage.
• Pregnant women have a 2–3 times higher risk of ICU admission with COVID-19 and a higher risk of preterm birth and pre-eclampsia.
• Your antibodies cross the placenta and pass into breast milk, protecting your baby in the first months of life when they cannot be vaccinated.
• In India, both Covaxin and Covishield have reassuring pregnancy safety data and are endorsed by FOGSI; register on CoWIN at any vaccination centre.
• Side effects (sore arm, fatigue, mild fever) are the same as in non-pregnant adults and settle in 1–2 days; paracetamol is the safe choice for relief.
• There is no credible evidence the vaccine causes infertility, miscarriage or birth defects — the worry comes from misinformation, not data.

Yes. The evidence base built up quickly during the pandemic and is now large and consistent. The first vaccine trials excluded pregnant women — this is the standard convention for any new vaccine, not a red flag — which is why early 2021 felt uncertain. Since then, big pregnancy cohorts in India, the US (the CDC v-safe registry), the UK, Europe and Israel have followed hundreds of thousands of vaccinated pregnant women.

The finding is reassuring and repeated everywhere: vaccinated women had no increase in miscarriage, stillbirth, preterm birth or birth defects compared with unvaccinated women. They did, however, have far less severe COVID-19 and fewer pregnancy complications from infection.

This applies across vaccine types — the mRNA vaccines (Pfizer, Moderna), the adenoviral-vector vaccines (Covishield/AstraZeneca), and the inactivated whole-virion vaccines (Covaxin, Sinopharm). The mRNA and inactivated vaccines have the largest pregnancy datasets. On the strength of this, the WHO, ACOG, RCOG, FOGSI and IAP all recommend vaccination at any trimester. If you are still planning a pregnancy, the same vaccines are recommended as part of preconception vaccination too.

• Reduced lung capacity and higher oxygen demand as the uterus grows
• A hypercoagulable (pro-clotting) state that raises the risk of severe illness
• Immune changes that protect the baby but can alter the response to infection
• Higher background risk if you are over 35, overweight, or have diabetes or high blood pressure

One of the biggest reasons to vaccinate in pregnancy is the gift it passes to your baby. From around 20 weeks onwards — and most strongly in the third trimester — your IgG antibodies cross the placenta to your baby. When you are vaccinated, those protective antibodies cross too, giving your newborn passive immunity for the first few months of life.

This matters because COVID-19 vaccines are not given to babies under 6 months, and severe COVID-19 does occur in young infants. Studies of vaccinated mothers have shown protective antibody levels in cord blood and lower rates of infant COVID-19 hospitalisation in the first months. Maternal vaccination is, in effect, the main way to protect a newborn before they are old enough for their own baby vaccinations.

The protection continues after birth if you breastfeed: your antibodies pass into breast milk, adding another layer of defence. This passive-antibody strategy is exactly how maternal whooping-cough and flu vaccines work too, so it is a well-established principle in obstetric care — and one more reason the benefits of breastfeeding extend to infection protection.

India ran one of the largest vaccination programmes in the world, delivering over 2 billion doses. Two vaccines dominate the maternal picture:

• Covaxin (BBV152) — an inactivated whole-virion vaccine from Bharat Biotech, developed with ICMR and the National Institute of Virology. It contains killed virus that cannot replicate or cause infection.
• Covishield (ChAdOx1) — the AstraZeneca–Oxford adenoviral-vector vaccine, manufactured at scale by the Serum Institute of India in Pune. It is the same vaccine used widely across the world as AstraZeneca.

• Sore, swollen arm at the injection site (very common, mild)
• Fatigue lasting 1–2 days (common)
• Mild fever and chills lasting 1–2 days (common)
• Headache and muscle aches (common)
• Mild nausea (less common)

Most side effects settle within a day or two. Paracetamol is the safe, recommended choice in pregnancy for a sore arm, headache or fever — take it after the vaccine for symptom relief rather than as a routine pre-medication. Rest, fluids and a light schedule for a day usually do the rest. A mild fever from the vaccine is not the same as illness and does not harm the baby; that said, if a fever is high or persists beyond 48 hours, check with your doctor, just as you would for any fever in pregnancy.

Genuinely serious reactions are rare and have been carefully monitored:

• Anaphylaxis (severe allergic reaction) is very rare — roughly 1 in 100,000 to 1 in 1,000,000 doses — which is exactly why you are observed for 15–30 minutes.
• Thrombosis with thrombocytopenia syndrome (TTS) is a very rare clotting event linked to adenoviral-vector vaccines, mostly seen in younger non-pregnant women. It is extremely rare in pregnancy, and FOGSI, RCOG and WHO all judge the benefit–risk balance with Covishield/AstraZeneca to be clearly favourable.
• Myocarditis is a very rare event linked to mRNA vaccines, mostly in young men.

COVID-19 vaccination sits within a small, well-established set of pregnancy vaccines. Knowing the whole picture helps you plan a single antenatal visit efficiently.

Tdap (tetanus, diphtheria, whooping cough) is recommended in every pregnancy, ideally between 27 and 36 weeks. Its main job is to protect your newborn against whooping cough (pertussis), which is dangerous in tiny babies, by passing antibodies across the placenta. India's Universal Immunization Programme has traditionally offered plain tetanus toxoid (TT) in pregnancy, but IAP and FOGSI now recommend Tdap (which adds the pertussis component) — worth asking for by name, especially in private antenatal care.

Influenza (flu) vaccine is recommended in any trimester during flu season (broadly October to March in much of India). Pregnant women are at higher risk of severe flu, and the vaccine protects both mother and baby. It must be the inactivated injectable flu vaccine, never the live nasal-spray version. See our guide on the pregnancy flu vaccine — when and where for the practical details.

Hepatitis B is given to non-immune women at risk of exposure, and is safe in pregnancy.

Live vaccines are not given in pregnancy — this includes MMR (measles–mumps–rubella), varicella (chickenpox) and yellow fever. If you are found to be non-immune to rubella at your booking visit, you receive MMR after delivery. Ideally, rubella and varicella immunity is sorted before conception, with a one-month wait before trying. If you are travelling, some travel vaccines are situational — inactivated ones are generally fine, live ones are avoided, and non-essential travel may be best deferred.

It is completely understandable to be cautious about anything new in pregnancy. The worries below are common, and they deserve straight answers grounded in evidence rather than dismissal.

"Will the vaccine reach or harm my baby?" No. mRNA vaccines deliver a short strip of mRNA that briefly instructs muscle cells to make the spike protein; the immune system learns to recognise it, and the mRNA is broken down within days. It does not cross the placenta or alter your baby's DNA. Adenoviral-vector vaccines (Covishield) use a non-replicating virus to carry the spike instructions — it cannot cause infection. Inactivated vaccines (Covaxin) contain killed virus that cannot replicate. There is no biological route for any of these to harm the pregnancy.

"Does it affect fertility?" This claim spread on social media early in the rollout and has been thoroughly studied since. Large fertility-clinic and IVF cohorts and population pregnancy registries show no effect on fertility, ovulation, implantation, miscarriage or live-birth rates — in women or men. Our deeper look at COVID-19 and fertility covers the evidence, including the reassuring data on sperm and menstrual cycles.

"Were Covaxin and Covishield properly tested in pregnant women?" Both now have substantial post-licensure pregnancy safety data from India and abroad (Covishield is the same vaccine as global AstraZeneca), and FOGSI and IAP specifically endorse both. The initial trial exclusion is the standard convention for new vaccines — dedicated pregnancy data is generated afterwards, which is exactly what happened.

"Isn't natural infection better than the vaccine?" Natural infection does build immunity — but only by going through the illness, which in pregnancy carries the elevated risks of severe disease and pregnancy complications described above. Vaccination gives protective immunity without paying that price. For someone trying to protect both herself and her pregnancy, that is not a close call.

When in doubt, the most reliable sources are the major medical bodies — WHO, CDC, ACOG, RCOG, FOGSI, IAP — and your own obstetrician, not unverified posts online.

If you were not vaccinated during pregnancy, you can and should be vaccinated after delivery — during the hospital stay or at your postpartum visit. You remain at raised risk in the early weeks, and your antibodies pass into breast milk to help protect your baby.

The vaccine is fully compatible with breastfeeding. There is no evidence the vaccine components themselves enter breast milk in any meaningful amount, and it does not affect your milk or your baby — unlike some foods and medicines that need care while breastfeeding, this one is simply safe.

The postpartum period is also the time to catch up on the live vaccines you couldn't have in pregnancy — MMR and varicella for non-immune women (avoid pregnancy for one month afterwards) — plus Tdap or flu if missed. Finally, ask the people around your baby to update their own vaccines. This cocoon strategy — surrounding a newborn with vaccinated caregivers — reduces the chance of the baby being exposed to whooping cough, flu or COVID-19 before their own first vaccines take effect.

The COVID-19 experience showed that maternal vaccination can be rolled out at scale and woven into routine antenatal care in India. That same model is now driving new vaccines designed specifically to protect newborns through maternal antibodies.

RSV (respiratory syncytial virus) vaccine for pregnancy was approved in the US and Europe in 2023, given around 32–36 weeks to protect babies from severe RSV in their first months. Availability in India depends on regulatory approval and national-programme decisions. Group B streptococcus (GBS) and cytomegalovirus (CMV) maternal vaccines are in development for the same reason — protecting the newborn before they can be vaccinated directly. The principles are the same ones COVID-19 vaccination made familiar: time the dose for best antibody transfer, confirm safety in pregnancy, and counsel clearly. The infrastructure built during the pandemic should make these future vaccines easier to introduce.

• Signs of a severe allergic reaction (difficulty breathing, swelling of the face or throat, widespread rash) — this is a medical emergency, call for help immediately
• Fever above 38°C that lasts beyond 48 hours, or any high fever you cannot bring down
• Severe or persistent headache, blurred vision, or shortness of breath in the days after an adenoviral-vector (Covishield) vaccine
• Severe, unusual leg pain or swelling, or chest pain (possible signs of a clot)
• Reduced or absent fetal movements, vaginal bleeding, leaking fluid, or signs of preterm labour — always evaluate these, vaccine or not

• WHO — COVID-19 vaccines: advice (including pregnancy)
• ACOG — COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
• RCOG — COVID-19 vaccines, pregnancy and breastfeeding
• FOGSI — Good Clinical Practice Recommendations on COVID-19 vaccination in pregnancy and lactation
• Ministry of Health and Family Welfare, Government of India — CoWIN / COVID-19 vaccination
• CDC — COVID-19 Vaccines While Pregnant or Breastfeeding